Wednesday, November 02, 2022 3:37:27 AM
Please don’t misunderstand me. This is the first time that I post on a board and I really do not feel comfortable in front of a laptop which I use as a simple typewriter. Actually, I was surprised and bewildered to see that my first message went out thrice and, moreover, in caps as you noted. Sincere apologies to all who may have been disturbed by this, and to moderators for the trouble I caused them. At 75, it is technology that has caught up with me.
Let me also be clear that my motivation is to contribute, when possible, to constructive discussions in the interest of all. In my post, I just wanted to contrast statements with on the ground realities in order to point out the misleading results that the gap between them may engender. I was not emitting any moral judgements in this respect, far from there.
To dissipate any doubts about my sincerity, allow me to give a glimpse about my mindset and the universe in which I have been evolving.
A drifter since birth, I have travelled extensively, and lived in the Middle East, North Africa, Europe and the US where, through work and scholarships, I obtained a BS, MA and MBA from three Ivy League universities. My multi-lingual skills have afforded me the immersion in disparate cultural spheres, meeting and interacting, de facto, with almost all nationalities the world counts. With time, this has come to be reflected in the diversity of my united family. Today, am a happy grandfather to three cosmopolitan boys.
My exposure to the diversity of the world from a very young age has informed my special interest in mysticism as a creative force that marries ethics and practice; in culture and its capacity to point to truth through beauty; and spirituality that opens the door to rise above our animal instincts in order to realize our human nature. Struck by the divorce between meaning and work, the paradox of a global society that planned for, and trained, everything except the human spirit, I long ago elected to devote my time to my family and others over the pursuit of money. Though the road wasn’t particularly easy, the outcome has been rewarding.
My constant focus has been to seek an understanding of who I am and what the beauty of life is all about. My quest has led me to engage in practice/realization to tend towards the virtues of harmony, serenity, respect and purity. I am here deeply indebted to Indian and Far Eastern cultural expressions. Yoga and Zen meditation have long become a part of my daily life, adding to what the long years of assiduous practice of one Budho form - Kinomichi (The Way of Energy) – has offered me.
Hope you would appreciate my saying am a long Amarin, hurt but definitely not embittered.
I reiterate my apologies to all and thank you for welcoming me to the board.
Best thoughts.
Recent AMRN News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 11:30:10 AM
- Amarin Board of Directors Announces CEO Transition • GlobeNewswire Inc. • 06/04/2024 11:30:00 AM
- Amarin Receives National Reimbursement for VAZKEPA® (icosapent ethyl) in Greece and Announces Exclusive Marketing and Commercialization Agreement with Vianex S.A. • GlobeNewswire Inc. • 05/28/2024 12:15:23 PM
- Amarin to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference • GlobeNewswire Inc. • 05/06/2024 12:00:00 PM
- Amarin Reports First Quarter 2024 Business Update and Financial Results • GlobeNewswire Inc. • 05/01/2024 11:00:00 AM
- Amarin Applauds HealthyWomen’s Citizen’s Petition Urging FDA To Take Further Action On Fenofibrate Prescribing in Patients at Risk of Cardiovascular Event • GlobeNewswire Inc. • 04/24/2024 06:00:01 PM
- Amarin Announces Results of Annual General Meeting of Shareholders • GlobeNewswire Inc. • 04/22/2024 12:00:25 PM
- Amarin to Report First Quarter 2024 Financial Results and Host Conference Call on May 1, 2024 • GlobeNewswire Inc. • 04/15/2024 12:00:00 PM
- Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ACC.24 • GlobeNewswire Inc. • 04/08/2024 12:00:00 PM
- New REDUCE-IT® Analyses Show VASCEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups • PR Newswire (Canada) • 04/08/2024 10:30:00 AM
- New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups • GlobeNewswire Inc. • 04/06/2024 07:30:00 PM
- Amarin Provides Update on VAZKEPA® (Icosapent Ethyl) Intellectual Property Portfolio in Europe • GlobeNewswire Inc. • 04/03/2024 12:00:00 PM
- Research Evaluating Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo • GlobeNewswire Inc. • 03/25/2024 12:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 03/04/2024 10:30:53 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/04/2024 01:00:24 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/29/2024 12:06:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 12:05:56 PM
- Amarin Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 02/29/2024 12:00:00 PM
- Amarin to Report Fourth Quarter and Full Year 2023 Financial Results and Host Conference on February 29, 2024 • GlobeNewswire Inc. • 02/15/2024 01:00:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 02/12/2024 01:00:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:31:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:30:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:30:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:30:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:30:22 PM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM